Learn More
Medchemexpress LLC Nateglinide | 105816-04-4 | MFCD00875706 | 99.95% | 100 MG

Supplier: Medchemexpress LLC HYB0422100MG
Nateglinide is a D-phenylalanine derivative that acts as an orally active, short-acting insulinotropic agent and a DPP IV inhibitor. It functions by inhibiting ATP-sensitive K+ channels in pancreatic β-cells and is utilized in the treatment of type 2 (non-insulin-dependent) diabetes mellitus. This product is intended for research use only and is not sold to patients.
- Acts as an orally active, short-acting insulinotropic agent
- Functions as a DPP IV inhibitor
- Inhibits ATP-sensitive K+ channels in pancreatic β-cells
- Used for the treatment of type 2 diabetes mellitus
- Inhibits dinitrophenol-induced KATP currents
- Stimulates human C-peptide secretion
- Improves postprandial glucose concentrations
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.